Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women. (Q52879856)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 January 2014

Language	Label	Description	Also known as
English	Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women.	scientific article published on 29 January 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

1 reference

based on heuristic

inferred from title

author name string

Adel H Karara

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Lester I Harrison

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Armen P Melikian

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Nagaraju Poola

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Dennis Morrison

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Dale Bourg

6

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Linda Bourg

7

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Christian Zurth

8

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

publication date

29 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

54

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

520-527

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

The evolutionary origin and significance of menopause

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

A prospective population-based study of menopausal symptoms

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Age of menopause and impact of climacteric symptoms by geographical region

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

The 2012 hormone therapy position statement of: The North American Menopause Society

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Estrogen-Progestin Replacement Therapy and Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Progestogens and venous thromboembolism among postmenopausal women using hormone therapy

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Hormone therapy and risk of myocardial infarction: a national register study

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Effects of transdermal estrogen replacement therapy on cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Safety and efficacy of a continuous once-a-week 17beta-estradiol/levonorgestrel transdermal system and its effects on vasomotor symptoms and endometrial safety in postmenopausal women: the results of two multicenter, double-blind, randomized, contro

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

An evaluation of bioequivalence of two 7-day 17beta-estradiol transdermal delivery systems by anatomical site

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG).

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Levonorgestrel. Clinical pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Low androstenedione/sex hormone binding globulin ratio increases fracture risk in postmenopausal women. The Women's Health in the Lund Area study.

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.238

21 January 2018

Identifiers

10.1002/JCPH.238

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/24474034

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52879856&oldid=1584855032"